Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Schizophrenia

Free Subscription Articles published in Br J Psychiatry Retrieve available abstracts of 86 articles: HTML format

Single Articles

August 2026
1. TEODORO TP
   Holodysphrenia and acute schizophrenia: Professor Barahona Fernandes's pioneering contribution to the nosology of acute transient psychoses - Psychiatry in history.
   Br J Psychiatry. 2026;229:252.
   PubMed    
   
   
   July 2026
2. RIUS-BONET J, Gras-Font J, Macip S
   Exploring ageing as a potential new therapeutic target for schizophrenia.
   Br J Psychiatry. 2026 Jul 27:1-3. doi: 10.1192/bjp.2026.10746.
   PubMed     Abstract available
   
   
   
3. MONCRIEFF J, Priebe S
   Relapse and the outcome of schizophrenia and recurrent psychosis: response to a Commentary.
   Br J Psychiatry. 2026 Jul 8:1. doi: 10.1192/bjp.2026.10732.
   PubMed    
   
   
   June 2026
4. BAUM ML, Blackman G, Al-Diwani A, Handel A, et al
   Ethical issues in the clinical use of diagnostic technologies for rare causes of psychosis.
   Br J Psychiatry. 2026 Jun 16:1-6. doi: 10.1192/bjp.2026.10675.
   PubMed     Abstract available
   
   
   May 2026
5. ABBOUD F, Ahrens J, Balles E, Bambini V, et al
   The functional relevance of a short assessment of formal thought disorder in psychosis.
   Br J Psychiatry. 2026 May 26:1-9. doi: 10.1192/bjp.2026.10650.
   PubMed     Abstract available
   
   
   
6. BECK K, Broome M, Farooq S, Gaughran F, et al
   New approaches to clinical research for people with schizophrenia.
   Br J Psychiatry. 2026 May 15:1-4. doi: 10.1192/bjp.2026.10657.
   PubMed     Abstract available
   
   
   
7. SMITH A, Griffin NP, Grana J, Buadze A, et al
   'Where you swim, she drowns': schizophrenia and Finnegans Wake (1939) - Psychiatry in literature.
   Br J Psychiatry. 2026;228:495-496.
   PubMed    
   
   
   
8. DE LA HOZ JF, Arias A, Service SK, Castano M, et al
   Characterisation of serious mental illness trajectories through transdiagnostic clinical features.
   Br J Psychiatry. 2026;228:446-453.
   PubMed     Abstract available
   
   
   April 2026
9. WILLIAMS R, Penington E, Gupta V, Rickett M, et al
   From early intervention in psychosis to intensive care: correlates of restrictive psychiatric practice in a national retrospective cohort study.
   Br J Psychiatry. 2026 Apr 30:1-11. doi: 10.1192/bjp.2026.10637.
   PubMed     Abstract available
   
   
   
10. FERNANDEZ-EGEA E, Garcia-Rizo C, Kirkpatrick B
    Schizophrenia and accelerated ageing: systematic review and future research directions.
    Br J Psychiatry. 2026 Apr 22:1-13. doi: 10.1192/bjp.2026.10606.
    PubMed     Abstract available
    
    
    
11. GHENCIULESCU A, Pearse A, Minichino A, Sampogna G, et al
    Transdiagnostic efficacy of lurasidone on depressive symptoms: systematic review and meta-analysis of randomised controlled trials.
    Br J Psychiatry. 2026;228:357-366.
    PubMed     Abstract available
    
    
    
12. WAGNER E, Korman N, Solmi M, Mortazavi M, et al
    Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis.
    Br J Psychiatry. 2026;228:348-356.
    PubMed     Abstract available
    
    
    
13. LAUNDERS N, Jackson CA, Hayes JF, John A, et al
    Characteristics of people with severe mental illness excluded from incentivised physical health checks in the UK: electronic healthcare record study.
    Br J Psychiatry. 2026;228:340-347.
    PubMed     Abstract available
    
    
    March 2026
14. WU X, Lu C, Kong H, Chen R, et al
    Recalibrating the epigenetic clock reveals divergent DNA methylation age signatures across schizophrenia, bipolar disorder and major depressive disorder.
    Br J Psychiatry. 2026 Mar 25:1-9. doi: 10.1192/bjp.2025.10508.
    PubMed     Abstract available
    
    
    
15. JULIA L, Ortiz-Garcia de la Foz V, Gonzalez-Segura A, Alemany M, et al
    Predicting early clinical recovery in first-episode psychosis: development and external validation of a clinically interpretable multivariable model.
    Br J Psychiatry. 2026 Mar 23:1-12. doi: 10.1192/bjp.2026.10581.
    PubMed     Abstract available
    
    
    
16. LEIGHTON SP, Leong IL, Machlanski D, Perry BI, et al
    Antipsychotic-induced weight gain in psychosis: causal mediation analysis and feasibility study of causal actionable prediction model development using counterfactuals to target obesity.
    Br J Psychiatry. 2026 Mar 9:1-10. doi: 10.1192/bjp.2026.10561.
    PubMed     Abstract available
    
    
    
17. OLIVER D, Fusar-Poli P
    Can critical components of effective early intervention in psychosis also advance early detection and preventive care for young people at risk?
    Br J Psychiatry. 2026 Mar 9:1-3. doi: 10.1192/bjp.2026.10593.
    PubMed     Abstract available
    
    
    February 2026
18. KUMARI V, Otermans PCJ
    Chatbot psychosis: moving beyond recognition to mechanistic understanding and harm reduction.
    Br J Psychiatry. 2026 Feb 9:1-3. doi: 10.1192/bjp.2026.10541.
    PubMed     Abstract available
    
    
    
19. KARA VM
    Cultural heritage tourism as an adjunct in schizophrenia.
    Br J Psychiatry. 2026 Feb 5:1-2. doi: 10.1192/bjp.2025.10532.
    PubMed    
    
    
    January 2026
20. CORBEIL O, Montalvo I, Labad J, Luykx JJ, et al
    Real-world studies in psychiatry: insights into antipsychotic-associated breast cancer risk and their broader implications.
    Br J Psychiatry. 2026;228:7-9.
    PubMed     Abstract available
    
    
    December 2025
21. FERNANDEZ-EGEA E
    Clozapine clinics at the crossroads and the opportunity to redesign services for people with chronic schizophrenia.
    Br J Psychiatry. 2025 Dec 18:1-2. doi: 10.1192/bjp.2025.10513.
    PubMed     Abstract available
    
    
    
22. ALEMAN-MORILLO C, Garcia-San-Martin N, Bethlehem RAI, Dorfschmidt L, et al
    Medication and atypical brain maturation in psychosis associated with long-term cognitive decline and symptom progression.
    Br J Psychiatry. 2025 Dec 11:1-11. doi: 10.1192/bjp.2025.10482.
    PubMed     Abstract available
    
    
    November 2025
23. AFE T, Ogunsemi O
    Revisiting Lambo's pioneering work: the role of cultural factors in paranoid psychosis among the Yoruba tribe - 70-year old perspective: commentary, Afe and Ogunsemi.
    Br J Psychiatry. 2025 Nov 24:1-2. doi: 10.1192/bjp.2025.10487.
    PubMed     Abstract available
    
    
    
24. DIEDERICH F, Oloyede E, Taylor D, Bachmann CJ, et al
    Economic evaluation of different haematological monitoring schemes for patients with treatment-resistant schizophrenia using clozapine.
    Br J Psychiatry. 2025 Nov 13:1-8. doi: 10.1192/bjp.2025.10424.
    PubMed     Abstract available
    
    
    
25. HOWES O, Kapi M, Bukala BR
    Does relapse matter? Insights from new data in schizophrenia.
    Br J Psychiatry. 2025 Nov 10:1-3. doi: 10.1192/bjp.2025.10470.
    PubMed     Abstract available
    
    
    
26. TREW A, Rodda J, Shergill SS
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders: commentary, Trew et al - CORRIGENDUM.
    Br J Psychiatry. 2025;227:824.
    PubMed    
    
    
    October 2025
27. LIU W, Wang C, Guo F, Guo M, et al
    Structural connectivity of striatal subregions in first-episode schizophrenia: links to positive symptoms and treatment response.
    Br J Psychiatry. 2025 Oct 24:1-8. doi: 10.1192/bjp.2025.10434.
    PubMed     Abstract available
    
    
    
28. PEI H, Jiang S, Hou C, Li H, et al
    Accelerated ageing unfolds along the sensorimotor-association cortical axis in schizophrenia: multi-site study.
    Br J Psychiatry. 2025 Oct 1:1-9. doi: 10.1192/bjp.2025.10364.
    PubMed     Abstract available
    
    
    September 2025
29. PATEL R
    Cannabis and psychosis: minimising harm while maximising therapeutic potential.
    Br J Psychiatry. 2025 Sep 11:1-2. doi: 10.1192/bjp.2025.10389.
    PubMed     Abstract available
    
    
    
30. MONCRIEFF J, Priebe S
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders: commentary, Moncrieff et al.
    Br J Psychiatry. 2025 Sep 8:1-2. doi: 10.1192/bjp.2025.
    PubMed    
    
    
    
31. WILKINSON H, Johns LC, Batchelor R, Lau-Zhu A, et al
    Cognitive behavioural therapy for sleep problems in psychosis: systematic review of effectiveness and acceptability - CORRIGENDUM.
    Br J Psychiatry. 2025 Sep 4:1. doi: 10.1192/bjp.2025.10420.
    PubMed    
    
    
    
32. PRIES LK, Prachason T, Arias-Magnasco A, Lin BD, et al
    Impact of puberty timing, status and oestradiol on psychotic experiences in the context of exposomic and genomic vulnerability to schizophrenia in female adolescents: longitudinal ABCD study.
    Br J Psychiatry. 2025 Sep 3:1-8. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    August 2025
33. DE PERI L, Mellacqua ZB
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders: commentary, De Peri et al.
    Br J Psychiatry. 2025 Aug 19:1. doi: 10.1192/bjp.2025.10370.
    PubMed    
    
    
    July 2025
34. KISELY S, Bull C, Newton-Howes G, Zirnsak T, et al
    Restricting community treatment orders to people with non-affective psychosis is needed to reduce use and improve subsequent outcomes: Queensland-wide cohort study.
    Br J Psychiatry. 2025 Jul 23:1-6. doi: 10.1192/bjp.2025.10317.
    PubMed     Abstract available
    
    
    
35. HASHIMOTO K
    Host microbiota in clozapine-induced ileus and pneumonia among people with schizophrenia.
    Br J Psychiatry. 2025 Jul 22:1-2. doi: 10.1192/bjp.2024.
    PubMed    
    
    
    
36. TREW A, Rodda J, Shergill SS
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders.
    Br J Psychiatry. 2025 Jul 21:1-2. doi: 10.1192/bjp.2025.
    PubMed    
    
    
    
37. ZHOU H, Luo H, Tang JY, Honer WG, et al
    Population-based study of long-term mortality risk associated with clozapine use among patients with schizophrenia.
    Br J Psychiatry. 2025 Jul 4:1-9. doi: 10.1192/bjp.2025.10312.
    PubMed     Abstract available
    
    
    June 2025
38. WILLIAMS R, Penington E, Gupta V, Quirk A, et al
    Critical components of 'Early Intervention in Psychosis': national retrospective cohort study.
    Br J Psychiatry. 2025 Jun 26:1-9. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
39. REILLY TJ, Chesney E, Al-Diwani A, Jewell A, et al
    Identification of menstrual psychosis cases using electronic health records.
    Br J Psychiatry. 2025 Jun 23:1-3. doi: 10.1192/bjp.2025.
    PubMed    
    
    
    
40. ANDREU-BERNABEU A, Gonzalez-Penas J, Mora A, Bernardo M, et al
    Linking prolonged childhood and adolescent loneliness to schizophrenia spectrum disorders: results from EU-GEI study.
    Br J Psychiatry. 2025 Jun 16:1-9. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
41. MUNOZ-CARACUEL M, Aleman-Morillo C, Garcia-San-Martin N, Garrido-Torres N, et al
    Predicting clinical and functional trajectories in individuals with first-episode psychosis by baseline deviations in grey matter volume.
    Br J Psychiatry. 2025 Jun 16:1-9. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
42. WETZLER SR, Madora MJ
    Puerperal insanity: history of postpartum psychosis.
    Br J Psychiatry. 2025;226:426-427.
    PubMed    
    
    
    May 2025
43. WILKINSON H, Johns LC, Batchelor R, Lau-Zhu A, et al
    Cognitive behavioural therapy for sleep problems in psychosis: systematic review of effectiveness and acceptability.
    Br J Psychiatry. 2025 May 22:1-16. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
44. O'HARE K, Lang U, Healy C, Kougianou I, et al
    Psychosis and bipolar disorder risk in child and adolescent mental health services in the UK: population cohort study.
    Br J Psychiatry. 2025 May 14:1-7. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
45. MUSTONEN A, Taipale H, Denissoff A, Ellila V, et al
    Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis.
    Br J Psychiatry. 2025 May 6:1-7. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
46. SHAJU A, Mishra A, Mohapatra D, Srinivasan A, et al
    Efficacy and safety of cholinergic modulators in patients with schizophrenia: meta-analysis of randomised controlled trials.
    Br J Psychiatry. 2025 May 2:1-11. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
47. RICHARDS-BELLE A, Launders N, Hardoon S, Man KKC, et al
    Prescribing of antipsychotics for people diagnosed with severe mental illness in UK primary care 2000-2019: 20-year investigation of who receives treatment, with which agents and at what doses.
    Br J Psychiatry. 2025;226:269-277.
    PubMed     Abstract available
    
    
    April 2025
48. MONCRIEFF J, Pillai E, Marston L, Lewis G, et al
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders.
    Br J Psychiatry. 2025 Apr 14:1-7. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
49. LYMAN M, Fanshawe JB, Brewin J, Fanshawe TR, et al
    Introduction of point-of-care blood testing in early intervention in psychosis services: effects on physical health screening.
    Br J Psychiatry. 2025 Apr 11:1-6. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    March 2025
50. COWMAN M, Hodgekins J, Griffiths SL, Frawley E, et al
    Cognitive and clinical profiles in first-episode psychosis and their relationship with functional outcomes.
    Br J Psychiatry. 2025 Mar 26:1-8. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
51. WHITING D, Glogowska M, Mallett S, Maughan D, et al
    Use of a violence risk prediction tool (Oxford Mental Illness and Violence) in early intervention in psychosis services: mixed methods study of acceptability, feasibility and clinical role.
    Br J Psychiatry. 2025 Mar 20:1-10. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    February 2025
52. LAGERBERG T, Lambe S, Paulino A, Yu R, et al
    Systematic review of risk factors for violence in psychosis: 10-year update.
    Br J Psychiatry. 2025;226:100-107.
    PubMed     Abstract available
    
    
    
53. ZANCHETA SB, de Alencar Quirino AH, Gomes SP, Nogueira GN, et al
    Adverse childhood experiences and psychological functioning among women with schizophrenia or bipolar disorder: population-based study: commentary, Zancheta et al.
    Br J Psychiatry. 2025;226:114-115.
    PubMed    
    
    
    January 2025
54. KANG S, Yang JS, Yun BH, Gelaye B, et al
    Antipsychotic continuation during pregnancy and risk of postpartum relapse in women with schizophrenia: nationwide register-based study.
    Br J Psychiatry. 2025 Jan 10:1-8. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
55. WANG F, Liu Z, Wang J, Li X, et al
    Aberrant controllability of functional connectome during working memory tasks in patients with schizophrenia and unaffected siblings.
    Br J Psychiatry. 2025 Jan 7:1-10. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
56. FERNANDEZ-EGEA E, McCutcheon RA
    Clozapine monitoring requirements: is it time for an update?
    Br J Psychiatry. 2025;226:1-3.
    PubMed     Abstract available
    
    
    December 2024
57. ZHOU J, Millier A, Aballea S, Francois C, et al
    Cost-effectiveness of ten commonly used antipsychotics in first-episode schizophrenia in the UK: economic evaluation based on a de novo discrete event simulation model.
    Br J Psychiatry. 2024 Dec 26:1-8. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
58. SMITH KA, Boyce N, Chevance A, Chiocchia V, et al
    Triangulating evidence from the GALENOS living systematic review on trace amine-associated receptor 1 (TAAR1) agonists in psychosis.
    Br J Psychiatry. 2024 Dec 23:1-9. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
59. NAUGHTON S, McGinty G, Duffy N, Marshall D, et al
    Intervening early across the lifespan: going beyond youth-focused psychosis care to meet the needs of women.
    Br J Psychiatry. 2024 Dec 4:1-3. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
60. YANG LH, Grivel MM, Blasco D, Girgis RR, et al
    Parsing stigma's relationship with the psychosocial functioning of youth identified as at clinical high risk for psychosis: evaluating whether symptom stigma or labelling stigma is stronger.
    Br J Psychiatry. 2024 Dec 4:1-9. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
61. CHESNEY E, Reilly TJ, Scott F, Slimani I, et al
    Psychosis associated with cannabis withdrawal: systematic review and case series.
    Br J Psychiatry. 2024 Dec 3:1-12. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    November 2024
62. GREENWOOD K, Jones C, Yaziji N, Healey A, et al
    The Early Youth Engagement (EYE-2) intervention in first-episode psychosis services: pragmatic cluster randomised controlled trial and cost-effectiveness evaluation.
    Br J Psychiatry. 2024 Nov 25:1-9. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
63. TREUR JL, Thijssen AB, Smit DJA, Tadros R, et al
    Associations of schizophrenia with arrhythmic disorders and electrocardiogram traits: genetic exploration of population samples.
    Br J Psychiatry. 2024 Nov 8:1-9. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
64. HALL J
    Schizophrenia - new treatments soon.
    Br J Psychiatry. 2024 Nov 8:1-2. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
65. TESLI N, Vaskinn A
    Violence and schizophrenia: let us take a deep breath and gain a meta-perspective.
    Br J Psychiatry. 2024;225:508-509.
    PubMed    
    
    
    October 2024
66. YANG JS, Kang S, Kim K, Tsai AC, et al
    Breast cancer risk among women with schizophrenia and association with duration of antipsychotic use: population-based cohort study in South Korea.
    Br J Psychiatry. 2024 Oct 31:1-7. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
67. NICHOLLS D, Budd J, Nunn P, French P, et al
    Investigating inequalities in patient outcomes for first-episode psychosis.
    Br J Psychiatry. 2024 Oct 10:1-7. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    September 2024
68. JIANG Y, Chang X, Feng J
    Towards a unified theory of the aetiology of schizophrenia.
    Br J Psychiatry. 2024 Sep 23:1-3. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
69. FERNANDEZ-EGEA E, Flanagan RJ, Taylor D, Gaughran F, et al
    Mortality associated with clozapine: what is the evidence?
    Br J Psychiatry. 2024;225:357-359.
    PubMed     Abstract available
    
    
    August 2024
70. LIU R, Li D, Ma Y, Tang L, et al
    Air pollutants, genetic susceptibility and the risk of schizophrenia: large prospective study.
    Br J Psychiatry. 2024 Aug 9:1-9. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
71. KIKUCHI Y, Kurosawa M, Sakata M, Takahashi Y, et al
    Effects of titration speed, gender, obesity and concomitant medications on the risk and onset time of clozapine-associated fever among Japanese patients with schizophrenia: retrospective review of charts from 21 hospitals.
    Br J Psychiatry. 2024 Aug 6:1-7. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
72. FAROOQ S, Hattle M, Kingstone T, Ajnakina O, et al
    Development and initial evaluation of a clinical prediction model for risk of treatment resistance in first-episode psychosis: Schizophrenia Prediction of Resistance to Treatment (SPIRIT).
    Br J Psychiatry. 2024 Aug 5:1-10. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
73. SHERGILL SS, Meshreky KM
    Towards a unified theory of the aetiology of schizophrenia: commentary, Shergill et al.
    Br J Psychiatry. 2024 Aug 5:1-2. doi: 10.1192/bjp.2024.
    PubMed    
    
    
    
74. KUMARI V
    Towards a unified theory of the aetiology of schizophrenia: commentary, Kumari.
    Br J Psychiatry. 2024;225:341-342.
    PubMed    
    
    
    July 2024
75. HUANG ML, Wei LC
    Psychological framework to understand interpersonal violence by forensic patients with psychosis: commentary, Huang & Wei.
    Br J Psychiatry. 2024 Jul 31:1. doi: 10.1192/bjp.2024.
    PubMed    
    
    
    May 2024
76. CHEN PH, Tsai SY, Chen PY, Pan CH, et al
    Lipid-modifying agents and risk of all-cause, natural and suicide mortality in schizophrenia: nationwide cohort study.
    Br J Psychiatry. 2024 May 16:1-9. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
77. FREEMAN D
    Developing psychological treatments for psychosis.
    Br J Psychiatry. 2024;224:147-149.
    PubMed     Abstract available
    
    
    
78. FERNANDEZ-EGEA E, Chen S, Sanguesa E, Gasso P, et al
    The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.
    Br J Psychiatry. 2024;224:164-169.
    PubMed     Abstract available
    
    
    April 2024
79. QI R, Qureshi M, Gire N, Chaudhry IB, et al
    Ethnic density and first episode psychosis in the British Pakistani population: findings from the East Lancashire Early Intervention Service.
    Br J Psychiatry. 2024 Apr 18:1-6. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    March 2024
80. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium - CORRIGENDUM.
    Br J Psychiatry. 2024 Mar 18:1. doi: 10.1192/bjp.2024.
    PubMed    
    
    
    February 2024
81. HASSIOTIS A, Noor M, Bebbington P, Ali A, et al
    Borderline intellectual functioning and psychosis: Adult Psychiatric Morbidity Survey evidence - CORRIGENDUM.
    Br J Psychiatry. 2024 Feb 13:1. doi: 10.1192/bjp.2024.
    PubMed    
    
    
    January 2024
82. MCCUTCHEON RA, Cannon A, Parmer S, Howes OD, et al
    How to classify antipsychotics: time to ditch dichotomies?
    Br J Psychiatry. 2024;224:20-25.
    PubMed     Abstract available
    
    
    November 2023
83. SAHIN D, Kambeitz-Ilankovic L, Wood S, Dwyer D, et al
    Algorithmic fairness in precision psychiatry: analysis of prediction models in individuals at clinical high risk for psychosis.
    Br J Psychiatry. 2023 Nov 8:1-11. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    October 2023
84. LAMBE S, Cooper K, Fazel S, Freeman D, et al
    Psychological framework to understand interpersonal violence by forensic patients with psychosis.
    Br J Psychiatry. 2023 Oct 20:1-8. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    
85. KOHLER-FORSBERG O, Ge F, Hauksdottir A, Thordardottir EB, et al
    Adverse childhood experiences and psychological functioning among women with schizophrenia or bipolar disorder: population-based study.
    Br J Psychiatry. 2023 Oct 18:1-7. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    
86. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium.
    Br J Psychiatry. 2023;223:485-492.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum